ReadTube
Back to Thomas Fordham Brewer MD MPH

Testosterone: What Every Man Over 40 Should Know

Thomas Fordham Brewer MD MPHJune 4, 20261h 28m
Topics45
Introduction and Personal Story0:03Why Low Testosterone Is Not Just a Number1:30Distinguishing Primary Testosterone Deficiency from Secondary Causes4:31The Vicious Cycle Involving Visceral Fat and Testosterone6:00Symptom Management vs. Root Cause Treatment10:00Historical Fears About Testosterone Therapy12:00Evidence Challenging the Prostate Cancer Fear16:00Cardiovascular Concerns and the Traverse Trial19:30Who Seeks Testosterone Therapy and Why21:30Access Issues and Legitimate Concerns22:30Ongoing Research and Clinical Approach25:30Testosterone in Women27:30Atrial Fibrillation Consideration28:35Additional Clinical Notes29:31Hypothyroidism and Testosterone Connection30:39Testosterone Use in Women31:31Symptoms vs. Lab Numbers33:33Total vs. Free Testosterone36:00Normal Ranges and Clinical Context39:33Timing and Frequency of Testing40:00Safety and Medical Evolution41:00Symptoms Warranting Evaluation42:00Recommended Testing Protocol44:30Foundational Lifestyle Interventions45:32Decision Framework49:00Prostate Cancer and Testosterone50:30Natural Approaches to Raising Testosterone54:00Clomid for Testosterone Therapy58:30Statins and Testosterone1:00:01TRT and Insulin Resistance1:00:30Testosterone and Visceral Fat Reduction1:01:33HRT and Testosterone for Post-Menopausal Women1:02:00Case Study: Low Testosterone Treatment at Age 671:03:33Interpreting A1C Results and Metabolic Health1:04:30Sleep Apnea and Circadian Rhythm Connection1:06:00Fasting Insulin Targets and Fat Burning1:08:30Strength Training Progress and Metabolic Impact1:11:30Sexual Function After Cardiac Stent Placement1:12:30Testosterone Replacement and Prostate Cancer Risk1:13:30Cold Hands and Circulation After Stent Placement1:14:31Intramuscular Testosterone Injection Technique1:17:00Medical Reference for Testosterone Safety1:18:32Low-Carb Diet Results and Cardiovascular Testing1:20:00Plaque Detection Methods: Calcium Score, CINT, and CTA with AI1:22:30Closing Statement on Aging and Vascular Health1:28:00
In a Nutshell

Low testosterone in men over 40 is frequently a downstream effect of obesity, insulin resistance, and poor sleep rather than simple aging, and treating the number alone without fixing these drivers fails to address root causes. Historical fears linking testosterone therapy to prostate cancer and heart disease are not supported by current evidence, including the Traverse trial, making therapy safe for appropriate patients when properly evaluated. Metabolic health optimization through sleep, resistance training, and diet must precede or accompany any testosterone treatment, with symptoms and full clinical context guiding decisions over lab values alone.

AI-Generated Notes

These notes were generated by AI and may contain inaccuracies.

A physician recommended starting testosterone treatment 10 years ago when the speaker was 57 years old. Despite running marathons with good energy and libido, the speaker declined. The conversation explores why that decision was made and why it has been reconsidered multiple times over the decade.

Men are more confused than ever about testosterone. Some doctors warn it is dangerous while clinics suggest every man over 50 should be on it. Both positions are incomplete.

By the end of the discussion, viewers will understand what the evidence actually shows, what a low number means and does not mean, and what proper evaluation looks like before receiving a prescription.

Most men assume low testosterone is simply what happens with aging. Testosterone does drop 1-2% per year starting in the 30s. By age 70, most men have meaningfully lower levels than at age 40. This is normal physiology, but aging is not the only driver.

In many or most men seeking treatment, the real drivers are metabolic disease, obesity, insulin resistance, poor sleep, and sleep apnea. Starting at age 18, over half of people have metabolic disease. By age 60-70 the percentage is much higher, and 90% of those affected do not know they have it.

These conditions can dramatically lower testosterone. A man may present with a low number and symptoms, receive a prescription from a clinic, yet no one asks whether the low testosterone is the primary problem or a downstream result of unaddressed metabolic issues.

Sign in to read the full notes

Get access to AI-generated notes, topic timestamps, and more.